Roundview Capital’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,000
Closed -$25.1K 346
2024
Q4
$25.1K Sell
3,000
-333
-10% -$3.16K ﹤0.01% 326
2024
Q3
$40.1K Buy
+3,333
New +$91.1K ﹤0.01% 332

Other funds holding XAGE

Roundview Capital's XAGE Position: Q1 2025 in Review

Roundview Capital sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2025, closing a stake of 3,000 shares — an estimated $25.1K sold.

Roundview Capital first reported a position in XAGE in Q3 2024 and held it in 2 quarters. The position peaked at $40.1K in Q3 2024. 22 funds tracked by Wall St. Rank hold XAGE as of Q1 2025.

  • Roundview Capital reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Roundview Capital sold 3,000 Longevity Health Holdings, Inc. Common Stock shares in Q1 2025, an estimated $25.1K.
  • Roundview Capital first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
  • Roundview Capital's Longevity Health Holdings, Inc. Common Stock position peaked at $40.1K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2025.

Based on Roundview Capital's 13F filing for Q1 2025, filed 6 May 2025.